Jazz Pharmaceuticals, Inc. (NASDAQ: JAZZ), a specialty pharmaceutical company, focuses their efforts on identifying, developing and commercializing innovative products designed to address unmet medical needs in neurology and psychiatry. Their goal as a company is to develop a broad portfolio of products through internal development and acquisition/in-licensing while utilizing a specialty sales force to promote products in target markets. For further information, visit the Company’s web site at www.jazzpharmaceuticals.com.
- 18 years ago
QualityStocks
Jazz Pharmaceuticals, Inc. (NASDAQ: JAZZ)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – Regentis Biomaterials Ltd. (NYSE American: RGNT) Moves GelrinC Closer to Regulatory and Commercial Milestones
Regentis Biomaterials (NYSE American: RGNT) is advancing its GelrinC hydrogel-based cartilage regeneration technology toward key clinical, regulatory…
-
Wrap Technologies Inc. (NASDAQ: WRAP) Positions Non-Lethal Innovation at the Center of Public Safety Reform
WRAP offerings illustrate a broader industry trend toward building connected ecosystems rather than standalone products.…
-
Brownfield Gold Projects Could Hold an Edge in Today’s Permitting Environment
Disseminated on behalf of Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) and may include paid advertising.…